Amylyx Pharmaceuticals Inc.
Clinical trials sponsored by Amylyx Pharmaceuticals Inc., explained in plain language.
-
New drug access for low blood sugar after Weight-Loss surgery
Disease control AVAILABLEThis expanded access program offers avexitide to people with post-bariatric hypoglycemia (dangerously low blood sugar) after Roux-en-Y gastric bypass. Eligible patients include those who completed the LUCIDITY trial or other avexitide studies. Participants receive a daily injecti…
Sponsor: Amylyx Pharmaceuticals Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New ALS drug targets nerve damage in early human trial
Disease control Recruiting nowThis early-stage trial tests a new medicine, AMX0114, in 48 adults with ALS. The drug aims to reduce a protein called calpain-2, which may damage nerves. The main goal is to check safety and how the body handles the drug, not yet to prove it works.
Phase: PHASE1 • Sponsor: Amylyx Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC